These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 9933749

  • 1. Hemodialysis-related nodulocystic acne treated with isotretinoin.
    Lin J, Shih I, Yu C.
    Nephron; 1999 Feb; 81(2):146-50. PubMed ID: 9933749
    [Abstract] [Full Text] [Related]

  • 2. Treatment of acne with intermittent isotretinoin.
    Goulden V, Clark SM, McGeown C, Cunliffe WJ.
    Br J Dermatol; 1997 Jul; 137(1):106-8. PubMed ID: 9274635
    [Abstract] [Full Text] [Related]

  • 3. Isotretinoin for acne vulgaris.
    al-Khawajah MM.
    Int J Dermatol; 1996 Mar; 35(3):212-5. PubMed ID: 8655243
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Relapse of acne following isotretinoin treatment: a retrospective study of 405 patients.
    Liu A, Yang DJ, Gerhardstein PC, Hsu S.
    J Drugs Dermatol; 2008 Oct; 7(10):963-6. PubMed ID: 19112761
    [Abstract] [Full Text] [Related]

  • 7. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
    Cyrulnik AA, Viola KV, Gewirtzman AJ, Cohen SR.
    Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
    Ahmad HM.
    Dermatol Ther; 2015 Sep; 28(3):151-7. PubMed ID: 25754162
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Medium dose isotretinoin for the treatment of acne.
    Hermes B, Praetel C, Henz BM.
    J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):117-21. PubMed ID: 9784036
    [Abstract] [Full Text] [Related]

  • 13. [Aggravation of acne by isotretinoin. 6 cases, predictive factors].
    Lehucher Ceyrac D, Chaspoux C, Sulimovic L, Morel P, Lefrancq H.
    Ann Dermatol Venereol; 1998 Aug; 125(8):496-9. PubMed ID: 9747314
    [Abstract] [Full Text] [Related]

  • 14. Long-term effects of isotretinoin in the treatment of severe nodulocystic acne.
    Falk ES, Stenvold SE.
    Riv Eur Sci Med Farmacol; 1992 Aug; 14(4):215-20. PubMed ID: 1305994
    [Abstract] [Full Text] [Related]

  • 15. Acne vulgaris in the elderly: the response to low-dose isotretinoin.
    Seukeran DC, Cunliffe WJ.
    Br J Dermatol; 1998 Jul; 139(1):99-101. PubMed ID: 9764156
    [Abstract] [Full Text] [Related]

  • 16. Roaccutane treatment guidelines: results of an international survey.
    Cunliffe WJ, van de Kerkhof PC, Caputo R, Cavicchini S, Cooper A, Fyrand OL, Gollnick H, Layton AM, Leyden JJ, Mascaró JM, Ortonne JP, Shalita A.
    Dermatology; 1997 Jul; 194(4):351-7. PubMed ID: 9252756
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Oral isotretinoin. How can we treat difficult acne patients?
    Leyden JJ.
    Dermatology; 1997 Jul; 195 Suppl 1():29-33; discussion 38-40. PubMed ID: 9310743
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.